| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |